Galectin-3: A Novel Biomarker Predicts Sudden Cardiac Death in Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy is a primary cardiac disease characterized by left ventricular hypertrophy, myocyte hypertrophy and irregularities and interstitial fibrosis in the absence of any cardiac or systemic diseases and may lead to sudden cardiac death (SCD). Galectin-3 is a β-galactoside-bindin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of the medical sciences 2018-12, Vol.356 (6), p.537-543
Hauptverfasser:	Emet, Samim, Dadashov, Mubariz, Sonsoz, Mehmet Rasih, Cakir, Mustafa Ozan, Yilmaz, Mustafa, Elitok, Ali, Bilge, Ahmet Kaya, Mercanoglu, Fehmi, Oncul, Aytac, Adalet, Kamil, Onur, Imran
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biomarkers - blood Cardiomyopathy, Hypertrophic - complications Death, Sudden, Cardiac - epidemiology Female Galectin 3 - blood Galectin-3 Humans Hypertrophic cardiomyopathy Male Middle Aged Risk Factors Risk score Sudden cardiac death Turkey - epidemiology Ventricular arrhythmias Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!